Profile
BDXB ISRG BDX BDXA ALC RMD
Company Name Becton, Dickinson and Company Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $13.69B $176.09B $65.60B $64.58B $45.56B $33.16B
Employees 77.00K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Mr. Thomas E. Polen Jr. Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. - Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM
Ratings
BDXB ISRG BDX BDXA ALC RMD
Quant Rating Score 4 3 3 5 3 3
Quant Rating Buy Neutral Neutral Strong Buy Neutral Neutral
Trading
BDXB ISRG BDX BDXA ALC RMD
Last Close $48.16 $493.72 $224.92 $59.24 $89.15 $225.79
High 52 $48.16 $610.45 $249.08 $59.24 $100.76 $257.65
Low 52 $48.16 $366.34 $220.02 $59.24 $77.58 $173.83
Price vs. 52 Week High 0 % -19.12 % -9.7 % 0 % -11.52 % -12.37 %
Price vs. 52 Week Low 0 % 34.77 % 2.23 % 0 % 14.91 % 29.89 %
Total Return
BDXB ISRG BDX BDXA ALC RMD
1 Month Return 0 % -16.26 % -0.41 % 0 % 1.12 % -4.57 %
3 Month Return 0 % -8.5 % -0.28 % 0 % 5.92 % -5.34 %
6 Month Return 0 % -0.06 % -4.49 % 0 % -11.52 % -9.94 %
9 Month Return 0 % 15.33 % -3.88 % 0 % -3.37 % 7.07 %
YTD Return 0 % -5.41 % -0.86 % 0 % 5.02 % -1.27 %
1 Year Return 0 % 26.79 % -5.42 % 0 % 1.16 % 16.52 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDXB ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) 1.77 % - 1.7 % 1.73 % 0.29 % 0.92 %
Dividend Paid and Capex Coverage Ration (TTM) 1.98 % 2.17 % 1.98 % 1.98 % 2.05 % 3.84 %
Dividend Per Share (TTM) 3.98 % - 3.89 % 3.89 % 0.26 % 2.07 %
Payout Ratio (TTM) 65.26 % - 65.26 % 65.26 % 13.01 % 23.76 %
Profitability
BDXB ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 45.22 % 67.46 % 45.22 % 45.22 % 55.61 % 57.94 %
Return on Assets TTM 3.16 % 12.39 % 3.16 % 3.16 % 3.35 % 17.49 %
Return on Equity TTM 6.73 % 15.31 % 6.73 % 6.73 % 6.43 % 25.05 %
Return on Capital Employed TTM 5.64 % 13.82 % 5.64 % 5.64 % 5.03 % 24.81 %
Net Income Per EBT TTM 88.43 % 86.87 % 88.43 % 88.43 % 81.05 % 81.35 %
EBT Per Ebit TTM 73.61 % 113.83 % 73.61 % 73.61 % 88.89 % 98.37 %
EBIT Per Revenue TTM 12.85 % 28.12 % 12.85 % 12.85 % 14.24 % 31.67 %
Cash Flow To Debt Ratio TTM 19.46 % - 19.46 % 19.46 % 36.06 % 175.81 %
Receivables Turnover TTM 7.82 6.16 7.82 7.82 4.77 5.73
Payables Turnover TTM - 14.05 - - 5.7 9.41
Inventory Turnover TTM 2.93 1.83 2.93 2.93 1.94 2.35
Fixed Asset Turnover TTM 312.63 % 179.75 % 312.63 % 312.63 % 205.17 % 734.05 %
Asset Turnover TTM 37.76 % 44.56 % 37.76 % 37.76 % 32.71 % 68.99 %
Operating Cash Flow Per Share TTM 12.61 6.78 12.61 12.61 3.75 10.05
Free Cash Flow Per Share TTM 10.14 3.66 10.14 10.14 2.19 9.45
Cash Per Share TTM 251.46 % 1126.07 % 251.46 % 251.46 % 370.15 % 355.4 %
Operating Cash Flow Sales Ratio TTM 17.68 % 28.91 % 17.68 % 17.68 % 18.66 % 29.96 %
Free Cash Flow Operating Cash Flow Ratio TTM 80.44 % 53.99 % 80.44 % 80.44 % 58.38 % 94.04 %
Cash Flow Coverage Ratios TTM 19.46 % - 19.46 % 19.46 % 36.06 % 175.81 %
Price To Free Cash Flows Ratio TTM 22 135.06 22.34 22.04 42.14 23.88
Price To Operating Cash Flows Ratio TTM 17.84 72.86 18.12 17.87 24.59 22.46
Price Cash Flow Ratio TTM 17.84 72.86 18.12 17.87 24.59 22.46
Income Statement (TTM)
BDXB ISRG BDX BDXA ALC RMD
Revenue $20.18B $8.35B $20.18B $20.18B $9.91B $4.69B
Gross Profit $9.13B $5.63B $9.13B $9.13B $5.51B $2.66B
Gross Profit Ratio 45.22% 67.5% 45.22% 45.22% 55.61% 56.67%
EBITDA $4.85B $2.67B $4.85B $4.85B $2.68B $1.53B
Net Income $1.71B $2.32B $1.71B $1.71B $1.02B $1.02B
EPS Diluted 5.86 6.42 5.86 5.86 2.05 6.92
Balance Sheet (MRQ)
BDXB ISRG BDX BDXA ALC RMD
Long Term Debt $17.94B $0B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $31.4B $2.21B $31.4B $31.4B $8.79B $2.01B
Total Equity $25.91B $16.53B $25.91B $25.91B $21.55B $4.86B
Total Investments $0.45B $6.81B $0.45B $0.45B $0.75B $0.17B
Total Debt $20.11B $0B $20.11B $20.11B $5.14B $0.87B
Total Assets $57.29B $18.74B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
BDXB ISRG BDX BDXA ALC RMD
Net Income $1.71B $2.34B $1.71B $1.71B $1.02B $1.02B
Inventory $0.1B $-0.83B $0.1B $0.1B $-0.05B $0.17B
Dividends Paid $-1.1B $0B $-1.1B $-1.1B $-0.13B $-0.28B
Operating Cash Flow $3.84B $2.42B $3.84B $3.84B $2.08B $1.4B
Capital Expenditure $-0.73B $-1.11B $-0.73B $-0.73B $-0.67B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.62
ALC Alcon Inc. 89.22
ANGO AngioDynamics, Inc. 9.05
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 147.715
ATRC AtriCure, Inc. 33.39
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 38.79
BAX Baxter International Inc. 35.08
BDX Becton, Dickinson and Company 225.97
BDXA Becton, Dickinson and Company 59.24
BLCO Bausch + Lomb Corporation 15.405
BLFS BioLife Solutions, Inc. 26.41
COO The Cooper Companies, Inc. 80.51
DXR Daxor Corporation 7.9
EKSO Ekso Bionics Holdings, Inc. 0.3891
FEMY Femasys Inc. 1.49
GCTK GlucoTrack, Inc. 0.3564
ETFs With Exposure to BDXB
Ticker ETF Name Weight Percentage Price
FCVT First Trust SSI Strategic Convertible Securities ETF 0.39 35.09
HSUN Hartford Sustainable Income ETF 0.134074 34.6057
QPFF American Century Quality Preferred ETF 0.68 35.4339
Unlock